📣From lead to pre-candidate nomination in 18 months. Explore the STORM Therapeutics case study

Contact
  • Integrated Drug Discovery

    Integrated Drug Discovery

    Overview

    We deliver truly integrated drug discovery programs. Our co-located teams accelerate compounds from target ID to candidate.

  • Target Identification & Validation

    Target Identification & Validation

    It’s important to lay strong foundations for successful drug discovery at this first stage of the process. Our integrated target identification and validation platform combines AI with expert insights, and rigorous lab validation to guide targets through robust evaluation, ready for hit discovery.

  • Hit Identification

    Hit Identification

    Validated, high-quality hits, delivered through integrated technologies and expert collaboration, give you a confident starting point for faster drug discovery.

  • Hit-to-Lead

    Hit-to-Lead

    High-quality hits with early proof of concept are de-risked and profiled, ready to accelerate your program towards lead optimization.

  • Lead Optimization

    Lead Optimization

    Turning promising leads into clinical candidates with speed, precision, and the scientific expertise to generate high-quality data and deliver real patient impact.

Featured Resources

  • Modalities

    Modalities

    Overview

    Delivering integrated, modality-agnostic drug discovery to tackle complex biology, accelerate development, and advance innovative therapies with confidence.

  • Small Molecules

    Small Molecules

    Expert small molecule discovery from target ID to scale-up, delivering candidates designed for success and market impact.

  • Peptides

    Peptides

    Transforming complex peptide concepts into next-generation therapies through integrated design, advanced analytics, and collaborative end-to-end discovery expertise.

  • Targeted protein degradation

    Targeted protein degradation

    Leveraging induced proximity and CHARMED technology to rapidly design, test, and optimize degraders for previously ‘undruggable’ targets.

  • ADCs

    ADCs

    Advancing next-generation ADCs through payload-focused design, integrated expertise, and collaborative innovation to deliver safer, more selective therapies.

  • Biologics

    Biologics

    Driving biologics innovation through integrated design, structural biology, and multidisciplinary expertise to accelerate next-generation therapies from concept to clinic.

Featured Resources

  • Therapeutic Areas

    Therapeutic Areas

    Overview

    Combining deep therapeutic expertise with translational insight to design strategies, reduce risk, and accelerate discovery programs toward clinical success.

  • Oncology and Immuno-Oncology

    Oncology and Immuno-Oncology

    Accelerating oncology drug discovery through integrated expertise, innovative modalities, and translational insight to deliver candidates with real clinical impact.

  • Inflammation and Immunology

    Inflammation and Immunology

    Driving immunology and inflammation drug discovery through tailored assays, translational models, and integrated expertise for faster clinical success.

  • Neuroscience

    Neuroscience

    Advancing CNS drug discovery through integrated models, translational biomarkers, and multidisciplinary expertise to overcome complexity and accelerate therapeutic innovation.

  • Metabolic Diseases

    Metabolic Diseases

    Designing and advancing differentiated small-molecule therapies for obesity and diabetes through integrated expertise, mechanistic insight, and translational strategies.

Featured Resources

  • CellCentric Lead Optimisation Campaign - CCS1477

    CellCentric Lead Optimisation Campaign - CCS1477

    Inobrodib, an exciting, first-in-class oral anti-cancer drug in clinical development by CellCentric, was collaboratively designed, synthesised and supported on its pre-clinical journey by an integrated project team at Sygnature Discovery. Inobrodib is now showing promising results in Phase I and II trials for multiple myeloma and other cancer types.

    Case study
  • About Sygnature

    About Sygnature

    At Sygnature Discovery, we deliver world-leading drug discovery solutions to accelerate your compound from idea to clinic.

  • Meet our Team

    Meet our Team

    Our leadership team brings diverse experience and insight, driving collaboration and innovation across drug discovery.

  • Careers

    Careers

    Explore careers at Sygnature Discovery and join a global team committed to science, collaboration, and integrity.

Blog

Thermofluor Stability Assays: More Than Just Measuring Protein Melting Temperature

Protein stability is a critical factor in many areas of drug discovery, influencing protein production, characterization, structural biology, and ligand screening. While thermal melting experiments are often used as a routine quality control tool, they can also provide valuable insights into protein behavior, buffer optimization, ligand binding, and protein function.

At Sygnature Discovery, thermal stability measurements are routinely used to assess protein quality and support downstream applications such as protein characterization and crystallization studies. Beyond simply determining melting temperature, these assays can provide a deeper understanding of how proteins respond to changes in their environment and interact with potential binding partners.

Measuring Protein Stability Using Thermofluor Assays

Several approaches exist for measuring protein thermal stability, but one of the most widely used is the thermofluor stability assay.

The assay uses environmentally sensitive fluorescent dyes that interact with proteins during thermal unfolding. Two commonly used dyes are:

  • SYPRO Orange, which associates with hydrophobic regions exposed during protein unfolding.
  • CPM, which reacts with cysteine thiol groups through maleimide chemistry.

When these dyes interact with proteins, their fluorescence increases significantly. By monitoring fluorescence while gradually increasing the temperature, it is possible to generate a protein unfolding curve and determine the apparent melting temperature (Tm).

The Tm is commonly used as a relative measure of protein stability under a given set of conditions.

SYPRO Orange is typically used for soluble proteins, while CPM is often preferred for membrane proteins due to the incompatibility of SYPRO Orange with detergent micelles.

Schematic illustration of thermofluor stability assays for soluble and membrane proteins. The diagram compares the use of SYPRO Orange dye, which detects exposed hydrophobic regions during unfolding of soluble proteins, with CPM dye, which binds exposed cysteine residues in membrane proteins. Fluorescence increases as proteins unfold, generating raw assay data that can be used to determine protein melting temperature and stability.
Figure 1. Overview of thermofluor stability assays.

Beyond Melting Temperature: Differential Scanning Fluorimetry

The true power of thermofluor stability assays lies not only in measuring Tm values, but also in comparing protein stability under different conditions.

Changes in melting temperature (ΔTm) can be used to assess how factors such as buffer composition, salt concentration, or ligand binding affect protein stability. This approach is commonly referred to as Differential Scanning Fluorimetry (DSF).

By evaluating thermostability shifts between conditions, researchers can obtain information that extends far beyond a simple measure of thermal denaturation.

Optimizing Protein Storage and Experimental Conditions

One common application of DSF is the optimization of protein storage conditions.

Buffer pH and ionic strength can have significant effects on protein stability, and their influence is often interdependent. By systematically varying parameters such as pH and salt concentration, it is possible to identify conditions that maximize protein stability.

This approach can help support protein production workflows by identifying buffer conditions suitable for storage, characterization, and structural studies.

Evaluating Protein-Ligand Interactions

Thermostability shift assays can also be used to assess the effect of ligands on protein stability.

In many cases, binding of a specific ligand stabilizes the protein and results in an increase in melting temperature. This approach can be applied to a wide range of molecule types, including fragments and lead compounds.

Thermofluor assays are frequently used during crystallization optimization to identify additives that improve protein stability. When implemented in high-throughput formats, DSF can also support drug discovery programs by rapidly assessing ligand-induced stabilization.

In some cases, ligand titration experiments can provide a proxy measure of binding affinity.

An example of ligand-induced stabilization following calcium titration is shown in Figure 2.

Investigating Protein Function and Mechanism

Thermostability assays can also provide insights into protein function.

Comparing the thermal stability of wild-type and mutant proteins may reveal the importance of specific residues involved in protein activity or mechanism. Changes in stability can help identify regions that contribute to structural integrity, ligand binding, or catalytic function.

As a result, thermofluor assays can support both protein characterization and mechanistic studies.

Differential scanning fluorimetry (DSF) analysis showing protein stability and ligand binding assessment. The top panel presents a buffer screen heatmap illustrating protein melting temperature (Tm) across different pH and sodium chloride concentrations. The lower left panels show additive screening results, highlighting conditions that increase or decrease protein stability. The lower right panel displays a ligand-binding curve, with increasing calcium concentration producing a concentration-dependent increase in protein melting temperature and an estimated dissociation constant (Kd) of 11.3 μM.
Figure 2. Examples of applications of thermofluor stability assays.
Left: protein stability can be assessed across different buffer conditions to identify formulations that maximise thermostability.
Right: ligand binding can increase protein stability, producing measurable thermal shifts that can be used to compare protein behaviour under different conditions.

Conclusion

Thermofluor stability assays are widely used to determine protein melting temperatures and assess protein quality. However, their value extends well beyond routine quality control.

By measuring changes in protein stability under different conditions, differential scanning fluorimetry can support buffer optimization, ligand screening, crystallization studies, and the investigation of protein function. These capabilities make thermofluor assays a versatile tool within modern protein science and drug discovery workflows.

Resources

Related Research & Resources

View all Articles